NCT06829030View on ClinicalTrials.gov

Comparison of the Efficacy of Diclofenac Sodium and Subcutaneous 5% Dextrose Injection in Low Back Pain.

PHASE1/PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

July 15, 2024

Primary Completion Date

February 15, 2025

Study Completion Date

February 28, 2025

Conditions
Low Back Pain, Mechanical
Interventions
DRUG

5% dextrose prolotherapy

The first group will receive subcutaneous 5% dextrose prolotherapy (approximately 75 patients), and the second group will receive intramuscular 75 mg diclofenac sodium injection

DRUG

Diclofenac 75mg/ml

The first group will receive subcutaneous 5% dextrose prolotherapy (approximately 75 patients), and the second group will receive intramuscular 75 mg diclofenac sodium injection (approximately 75 patients).

Trial Locations (1)

68000

Aksaray University Education and Research Hospital, Aksaray

All Listed Sponsors
lead

Aksaray University Training and Research Hospital

OTHER